Skip to main content

Month: January 2024

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock

ANN ARBOR, Mich., Jan. 18, 2024 (GLOBE NEWSWIRE) — Esperion Therapeutics, Inc. (“Esperion”, “we”, “us” or “our”) (Nasdaq: ESPR) announced today the pricing of its previously announced underwritten public offering of 56,700,000 shares of its common stock at a public offering price of $1.50 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Esperion. In addition, Esperion granted the underwriters a 30-day option to purchase up to an additional 8,505,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Esperion, are expected to be approximately $85.1 million, excluding any exercise of the...

Continue reading

Winnebago Industries Announces Pricing of $300 Million Offering of Convertible Senior Notes for Refinancing 2025 Maturities

EDEN PRAIRIE, Minn., Jan. 18, 2024 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO) (the “Company”), a leading outdoor lifestyle product manufacturer, priced $300 million aggregate principal amount of 3.250% convertible senior notes due 2030 (the “notes”) in a previously announced private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, the Company has granted the initial purchasers a 13-day option to purchase up to an additional $50 million aggregate principal amount of notes. The notes will bear interest at a rate of 3.250% per year, payable semi-annually in arrears on January 15 and July 15 of each year, beginning July 15, 2024. The notes will mature on January 15, 2030,...

Continue reading

NowVertical Group Comments on Press Release Issued by Daren Trousdell

TORONTO, Jan. 18, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (“NowVertical” or the “Company”) (TSX-V: NOW) (OTCQB: NOWVF), a leading data analytics and AI solutions company, responds to a press release issued by Daren Trousdell, a shareholder of NowVertical and a former officer and director of the Company. In connection with Mr. Trousdell’s resignation as an officer and director of the Company at the end of May 2023, Mr. Trousdell signed a separation agreement (the “Separation Agreement”). Among other things, Mr. Trousdell agreed that, until December 31, 2024:he would not engage in any attempts “to influence the management, board or policies of the Company”; he would not engage in “any discussions” with other shareholders or “announce or disclose” any “intention or desire” in connection with the management, board or policies...

Continue reading

Vishay Intertechnology Upgrades TSOP18xx, TSOP58xx, and TSSP5xx Series IR Receiver Modules With New In-House IC

Devices Offer Drop-in Replacements for Existing Solutions With Lower Current Consumption, Wider Voltage Range, and Improved ESD Robustness, Dark-Ambient Sensitivity, and Performance Under Strong DC Light MALVERN, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has upgraded its TSOP18xx, TSOP58xx, and TSSP5xx series of infrared (IR) receiver modules for remote control, proximity sensing, and light barrier applications. Offered in Minicast packages, the enhanced solutions provide drop-in, plug and play replacements for existing devices in the series while offering 50 % lower current consumption, improved ESD robustness to 12 kV, a wider supply voltage range from 2.0 V to 5.5 V, 20 % higher dark-ambient sensitivity, and improved performance under strong DC light. Devices in the...

Continue reading

VCI Global Announces Closing of $2.75 Million Public Offering

KUALA LUMPUR, Malaysia, Jan. 18, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) today announced the closing of its previously announced public offering of 2,200,000 the Company’s ordinary shares and accompanying Series A warrants to purchase up to 2,200,000 ordinary shares (“Series A Warrants”) and Series B warrants to purchase up to 2,200,000 ordinary shares (“Series B Warrants”, together with Series A Warrants, collectively the “Series Warrants”) at a combined offering price of $1.25 per ordinary share and associated Series Warrants. The Series Warrants have an exercise price of $1.25 per share and are immediately exercisable upon issuance. The Series A Warrants will expire five years following the initial exercise date, and the Series B Warrants will expire eighteen months following...

Continue reading

Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company

New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) — Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China. Pursuant to the Merger Agreement, BOWN’s wholly owned subsidiary, Bowen Merger Sub, a Cayman Islands exempted company, will merge (the “Merger” or the “Business Combination”) with and into Qianzhi Group Holding (Cayman) Limited, parent of Qianzhi BioTech and an exempted company incorporated with limited liability in the Cayman Islands (“NewCo”), with NewCo being the surviving company of the Merger and becoming a wholly-owned subsidiary...

Continue reading

Targa Resources Corp. Announces Quarterly Dividend and Timing of Fourth Quarter 2023 Earnings Webcast

HOUSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced its quarterly dividend on common shares with respect to the fourth quarter of 2023. Targa announced today that its board of directors has declared a quarterly cash dividend of $0.50 per common share, or $2.00 per common share on an annualized basis, for the fourth quarter of 2023. This cash dividend will be paid February 15, 2024 on all outstanding common shares to holders of record as of the close of business on January 31, 2024. For the first quarter of 2024, Targa intends to recommend to its Board of Directors an increase to its common dividend to $0.75 per common share or $3.00 per common share annualized. The recommended common dividend per share increase, if approved, would be effective...

Continue reading

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah where the Precise Tumor Test is currently performed. The acquisition is expected to close on February 1, 2024, subject to customary closing conditions. By bringing the Precise Tumor and Precise Liquid tests in house, Myriad will open up new opportunities for innovation, growth, and continued development of its oncology portfolio. “With this acquisition, we’re deepening our commitment to our oncology business while also generating...

Continue reading

Hubbell to Announce Fourth Quarter 2023 Results on January 30, 2024

Shelton, CT, Jan. 18, 2024 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) today announced it will release its fourth quarter 2023 financial results prior to the opening of the market on January 30, 2024. The Company will then webcast its Analysts’ Conference Call to discuss the results at 10:00 AM ET. The full text of the press release announcing the results will be posted on Hubbell’s corporate website under the Press Release section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Press Releases” from the drop-down menu. The live audio of the conference call and accompanying materials will also be available and can be accessed by visiting Hubbell’s Events and Presentations section. You...

Continue reading

Irish Residential Properties Sub-Fund 1: Form 8.3 – Irish Residential Properties REIT PLC

Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser Irish Residential Properties Sub-Fund 1(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Irish Residential Properties REIT Plc(d)   If an exempt fund manager connected with an offeror/offeree, state...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.